(Q44008328)

28 November 2017

A placebo-controlled study of high dose buprenorphine in opiate dependents waiting for medication-assisted rehabilitation in Oslo, Norway (English)

1 reference

28 November 2017

1 reference

1 reference

6

1 reference

28 November 2017

5

Magnus P

1 reference

28 November 2017

Krook AL

1

1 reference

28 November 2017

Brørs O

2

1 reference

28 November 2017

Dahlberg J

3

1 reference

28 November 2017

Grouff K

4

1 reference

28 November 2017

Waal H

7

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

97

1 reference

28 November 2017

5

1 reference

28 November 2017

533-542

1 reference

A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence

28 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Subjective well-being: Three decades of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Comparison of buprenorphine and methadone maintenance in opiate addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Trends in opiate-related deaths in the United Kingdom and Australia, 1985-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Double-blind randomized trial of buprenorphine and methadone in opiate dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Dose-response effects of methadone in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

How well can a few questionnaire items indicate anxiety and depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Clinical pharmacology of buprenorphine: ceiling effects at high doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

Drug treatment on demand--not.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1360-0443.2002.00090.X

10.1046/J.1360-0443.2002.00090.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference